Policy & governance of innovative technologies

Regulations, standards and guidelines to ensure safety, quality and efficacy are an integral part of the development of technological advances, particularly in life sciences. Innogen’s research on the governance systems we adopt for innovative technologies, how such choices are made and their impact on future innovation trajectories, the fate of future sectors of the economy, and the competitive advantage of nations, is internationally unique.

Projects

SPRE webinar on working with policymakers

16 June 2020

On the 12th June, Nick Bibby, Director of the Scottish Policy and Research Exchange, led an online discussion with over 20 Innogen and OU Scotland researchers on how to engage with the world of policy.

Joyce Tait delivers keynote presentation at Bloomsbury SET conference

18 March 2021

Innogen co-director Joyce Tait gave a keynote presentation at the virtual Bloomsbury SET conference focused on infectious diseases and antimicrobial resistance. Her talk in the first session of the conference: “Interdisciplinary knowledge exchange to tackle global health challenges” highlighted some of the Innogen’s work on regulatory adaptation to support the development of new antimicrobial drugs and rapid diagnostics.

Reasons to be cheerful, one, two, three.

8 November 2021

Professor Chris Warkup is optimistic about the UK Government's Innovation policy, read his blog post to find out why.

Prof Joyce Tait calls on the Scottish Government to reconsider its opposition to gene-edited crops

31 May 2022

Speaking to reporter Max Stephens from The Daily Telegraph, Innogen’s Founding Director, said that rejecting the legislation currently under consideration in England that will allow gene-edited products to be grown and sold, will mean Scotland will lose out.

Extractive economic and political institutions in African countries have locked-in the pharmaceutical sector into industrial under-development.

8 March 2023

In a new article published in Frontiers in Research Metrics and Analytics, Geoff Banda analyses the impact of extractive economic and political institutions on the industrial development of the African pharmaceutical sector.